《MedRxiv,4月3日,Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-05
  • Simple model for Covid-19 epidemics - back-casting in China and forecasting in the US

    View ORCID ProfileSlav W Hermanowicz

    doi: https://doi.org/10.1101/2020.03.31.20049486

    This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

    Abstract

    In our previous work, we analyze, in near-real time, evolution of Covid-19 epidemic in China for the first 22 days of reliable data (up to February 6, 2020). In this work, we used the data for the whole 87 days (up to March 13, 2020) in China and the US data available till March 31 (day 70) for systematic evaluation of the logistic model to predict epidemic growth. We sequentially estimated sets of model parameters (maximum number of cases K, growth rate r, and half-time t0) and the epidemic "end time" t95 (defined as the time when the number of cases, predicted or actual, reached 95% of the maximum). The estimates of these parameters were done for sequences of reported cases growing daily (back-casting for China and forecasting for the US). In both countries, the estimates of K grew very much in time during the exponential and nearly exponential phases making longer term forecasting not reliable. For the US, the current estimate of the maximum number of cases K is about 265,000 but it is very likely that it will grow in the future. However, running estimates of the "end time" t95 were in a much smaller interval for China (60 - 70 days vs. the actual value of 67). For the US, the values estimated from the data sequences going back two weeks from now range from 70 to 80 days. If the behavior of the US epidemic is similar to the previous Chinese development, the number of reported cases could reach a maximum around April 10 to 14.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.03.31.20049486v1
相关报告
  • 《MedRxiv,3月16日,Rational evaluation of various epidemic models based on the COVID-19 data of China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-17
    • Rational evaluation of various epidemic models based on the COVID-19 data of China Wuyue Yang, Dongyan Zhang, Liangrong Peng, Changjing Zhuge, Liu Hong doi: https://doi.org/10.1101/2020.03.12.20034595 Abstract During the study of epidemics, one of the most significant and also challenging problems is to forecast the future trends, on which all follow-up actions of individuals and governments heavily rely. However, to pick out a reliable predictable model/method is far from simple, a rational evaluation of various possible choices is eagerly needed, especially under the severe threat of COVID-19 epidemics which is spreading worldwide right now. In this paper, based on the public COVID-19 data of seven provinces/cities in China reported during the spring of 2020, we make a systematical investigation on the forecast ability of eight widely used empirical functions, four statistical inference methods and five dynamical models widely used in the literature. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《MedRxiv,3月6日,Data-Based Analysis, Modelling and Forecasting of the COVID-19 outbreak》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-07
    • Data-Based Analysis, Modelling and Forecasting of the COVID-19 outbreak Cleo Anastassopoulou, Lucia Russo, Athanasios Tsakris, Constantinos Siettos doi: https://doi.org/10.1101/2020.02.11.20022186 Abstract Since the first suspected case of coronavirus disease-2019 (COVID-19) on December 1st, 2019, in Wuhan, Hubei Province, China, a total of 40,235 confirmed cases and 909 deaths have been reported in China up to February 10, 2020, evoking fear locally and internationally. Here, based on the publicly available epidemiological data for Hubei, China from January 11 to February 10, 2020, we provide estimates of the main epidemiological parameters. In particular, we provide estimation of the the case fatality and case recovery ratios, along with their 90% confidence intervals and on the basis of a Susceptible-Infected-Recovered-Dead (SIRD) model we provide estimations of the basic reproduction number (R0), the infection rate. By calibrating the parameters of the SIRD model to the reported data, we also attempt to forecast the evolution of the of the outbreak at the epicenter three weeks ahead, i.e. until February 29. As the number of infected individuals, especially of those with asymptomatic or mild courses, is suspected to be much higher than the official numbers, which can be considered only as a subset of the actual numbers of infected and recovered cases in the population, we have repeated the calculations under a second scenario that considers twenty times the number of confirmed infected cases and forty times the number of recovered, leaving the number of deaths unchanged. Based on the reported data, the expected value of R0 as computed considering the period from the 11th of January until the 18th of January, using the official counts of confirmed cases was found to be ~4.6, while the one computed under the second scenario was found to be ~3.2. Thus, based on the SIRD simulations, the estimated average value of R0 was found to be ~2.6. Our forecasting flashes a note of caution for the presently unfolding outbreak in China. Based on the official counts for confirmed cases, the simulations suggest that the cumulative number of infected could reach 140,000 (with an upper bound of 700,000) by February 29. Regarding the number of deaths, simulations forecast that on the basis of the up to the 10th of February data and estimations of the actual numbers of infected and recovered in the population, the death toll might exceed 3,200 by February 29. However, our analysis further reveals a significant decline of the case fatality ratio to which various factors may have contributed, such as the severe control measures taken in Hubei, China (e.g. quarantine and hospitalization of infected individuals), but mainly because of the fact that if the actual cumulative numbers of infected and recovered cases in the population are significantly higher (here of the order of twenty times) for the infected and ten times higher for the recovered than reported, thus resulting in a much lower case fatality ratio significantly below 1%. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.